Didier Caizergues

Didier Caizergues, Director, Department of International Regulatory Affairs, GENETHON. A Doctor in Pharmacy who holds a degree in Health law. He enjoyed a long career in the field of Regulatory Affairs. He began his career as a consultant with International Drug Development (IDD) but soon joined the company SYNTHELABO in its Research and Development center where he worked for nine years. In this office, Dr. Didier Caizergues oversaw the registration of new molecules that had evolved from cardiovascular, urological, and anti-depressive research. He later headed up the international registration department for the Pierre Fabre group and for the next six years he practiced in the fields of anti-cancer drugs, anti-depressants, and orphan diseases. In 2001 he joined the GENETHON as Director of International Regulatory Affairs where he set up a regulatory affairs department specializing in gene and cell therapies in the fields of rare diseases. He obtained several clinical trials authorization in European countries and US for gene therapy products with lentivirus and AAV in the fields of muscular dystrophies and pediatric immunodeficiencies. He is also in charge of the assessment of new molecules or molecules already marketed still in the field of rare diseases in different working groups in European projects (Treat-NMD).